IO Biotech Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for IO Biotech stock have an average target of 9.33, with a low estimate of 6.00 and a high estimate of 12. The average target predicts an increase of 763.89% from the current stock price of 1.08.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$6.00	$9.33	$10	$12
Change	+455.56%	+763.89%	+825.93%	+1011.1%

Analyst Ratings

The average analyst rating for IO Biotech stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	1	1	1	1	1	1
Buy	2	2	2	2	2	2
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Emily Bodnar HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $12	Strong Buy	Reiterates	$12	+1,011.11%	Mar 5, 2025
Emily Bodnar HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $12	Strong Buy	Reiterates	$12	+1,011.11%	Nov 12, 2024
Emily Bodnar HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $12	Strong Buy	Reiterates	$12	+1,011.11%	Nov 6, 2024
Matthew Harrison Morgan Stanley	Morgan Stanley	Buy Maintains $4 → $6	Buy	Maintains	$4 → $6	+455.56%	Sep 16, 2024
Emily Bodnar HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $12	Strong Buy	Reiterates	$12	+1,011.11%	Sep 16, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

266.45M

from 167.27M

59.29%

from 167.27M

Revenue Next Year

n/a

from 266.45M

EPS This Year

-1.39

from -1.98

EPS Next Year

-1.32

from -1.39

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028	FY 2029
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028	Dec 31, 2029
Revenue	-	-	18.16M	83.15M	167.27M	266.45M
Revenue Growth	-	-	-	357.91%	101.17%	59.29%	-	-
EPS	-70.64	-82.36	-17.30	-2.48	-1.98	-1.39	-1.32	-1.13
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	7	7	7

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026
High	n/a	n/a	48.8M
Avg	n/a	n/a	18.2M
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2024	2025	2026
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2024	2025	2026
High	-1.37	-1.08	-0.88
Avg	-1.39	-1.32	-1.13
Low	-1.38	-1.47	-1.48

EPS Growth

EPS Growth	2024	2025	2026
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.